Sage Therapeutics, Inc. (SAGE): Price and Financial Metrics

Sage Therapeutics, Inc. (SAGE)

Today's Latest Price: $68.67 USD

5.38 (8.50%)

Updated Dec 11 4:00pm

Add SAGE to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 325 in Biotech

See all "A" rated Strong Buy stocks

SAGE Stock Summary

  • Sage Therapeutics Inc's capital turnover -- a measure of revenue relative to shareholder's equity -- is better than just 7.17% of US listed stocks.
  • SAGE's price/sales ratio is 4,607.77; that's higher than the P/S ratio of 99.88% of US stocks.
  • As for revenue growth, note that SAGE's revenue has grown -98.21% over the past 12 months; that beats the revenue growth of just 0.53% of US companies in our set.
  • If you're looking for stocks that are quantitatively similar to Sage Therapeutics Inc, a group of peers worth examining would be VHC, TGTX, CNCE, CBMG, and ZYNE.
  • Visit SAGE's SEC page to see the company's official filings. To visit the company's web site, go to
SAGE Daily Price Range
SAGE 52-Week Price Range

SAGE Stock Price Chart More Charts

SAGE Price/Volume Stats

Current price $68.67 52-week high $193.56
Prev. close $63.29 52-week low $56.50
Day low $64.48 Volume 3,187,648
Day high $69.68 Avg. volume 579,297
50-day MA $135.79 Dividend yield N/A
200-day MA $159.12 Market Cap 3.56B

Sage Therapeutics, Inc. (SAGE) Company Bio

Sage Therapeutics is a clinical-stage biopharmaceutical company committed to developing and commercializing novel medicines to treat life-threatening, rare central nervous system, or CNS, disorders. The company was founded in 2010 and is based in Cambridge, Massachusetts.

SAGE Latest News Stream

Event/Time News Detail
Loading, please wait...

SAGE Latest Social Stream

Loading social stream, please wait...

View Full SAGE Social Stream

SAGE Price Returns

1-mo -52.42%
3-mo -57.32%
6-mo -60.59%
1-year -36.32%
3-year 37.07%
5-year 93.06%
YTD -28.31%
2018 -41.84%
2017 222.58%
2016 -12.42%
2015 59.29%
2014 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.4865 seconds.